report adjust ep consensu
expect higher estim strong organ growth better-
than-anticip adjust oper margin perform lower-than-
expect share count drove upsid rel adjust
report basi syk revenu increas year-over-year
million consensu expect million
forecast million adjust result adopt
account standard codif lower report
revenu adjust sg expens approxim million
revenu growth would exclud acquisit
chang foreign currenc exchang rate syk sale improv
organ forecast led better result
anticip instrument organ medic
organ spine mid-single-digit organ neurotechnolog
mid-teen organ also remain standout perform quarter
adjust result adopt adjust
oper margin improv bp year-over-year
estim higher end compani expect
least bp adjust oper margin expans year quarter
benefit transform growth program off-set
dilut impact novadaq entellu acquisit adjust oper
follow strong second quarter rais outlook organ
growth addit compani increas
adjust ep guidanc versu consensu
expect posit organ growth adjust oper margin
trend expect off-set less favor anticip adjust ep
impact currenc benefit expect versu previous
rais adjust ep estim
reflect compani out-performance continu expect
total debt total asset
deliv anoth quarter better-than-expect organ growth
upsid consensu adjust ep estim addit weak year
margin perform encourag improv perform
area increas confid compani slightli exceed
upper end annual target bp adjust oper margin
expans particularli anniversari suppli headwind relat
product hurrican maria overal remain posit longer-
term outlook maintain buy rate new price target
import pleas read disclosur disclaim page report
report adjust ep consensu expect higher
estim strong revenu better-than-anticip adjust oper margin perform lower-than-
expect share count drove upsid rel adjust ep forecast
report basi syk revenu increas year-over-year million
consensu expect million forecast million adjust result
adopt account standard codif lower report revenu adjust
sg expens approxim million revenu growth would exclud
acquisit chang foreign currenc exchang rate syk sale improv organ
forecast
stryker adjust incom statement analysisnorthcoast research million except percentag per share sg interest incom incom margin incom medsurg neurotechnolog compani report northcoast research estim factset result reflect adopt account standard codif lower report revenu adjust sg expens million
divis standpoint strong result syk medsurg equip neurotechnolog spine busi
drove upsid rel organ growth forecast
medsurg equip achiev organ growth forecast
quarter medic organ growth remain particularli strong organ led continu favor
result core medic product stretcher hospit bed physio-control well return growth
product sale headwind product suppli issu lessen addit syk instrument busi
deliv improv perform organ led power surgic instrument roll-out
strength two area help off-set slower quarter endoscopi face difficult
comparison quarter
corporationtot compani organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-year compani report corpor organ growth analysiscategorynorthcoastreportedtot compani organ orthoped medsurg equip neurotechnolog spine compani report northcoast research estim
neurotechnolog spine product achiev organ growth
forecast similar recent quarter neurotechnolog sale except strong mid-teen organ
exclud entellu acquisit led ischem stroke busi meaning contribut
hemorrhag stroke neuro power instrument cmf product categori well surprisingli syk spine
organ growth also acceler posit mid-single-digit rang exclud vexim acquisit aid
orthoped product syk sale increas organ estim
quarter trauma extrem organ growth remain strong sale compani
orthoped product weaker anticip organ despit favor mako instal
instal addit compani combin hip knee organ growth
forecast
stryker corporationmedsurg equip organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-yearsourc compani report corporationneurotechnolog spine organ growth analysissourc compani report two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day knee implant achiev organ growth appear well better market rate
modestli forecast quarter syk knee implant organ growth organ
continu benefit increas demand cementless triathlon tritanium knee system addit mako
system sale competit account increas surgeon train mako total knee implant
applic roughli versu syk earn call total case
perform syk mako total knee roughli
hip implant achiev organ growth similar forecast modestli
ahead market rate overal encourag syk hip result particularli given focu key
differenti knee mako total knee applic cementless knee offer within orthoped divis
adjust result adopt adjust oper margin improv bp
year-over-year estim higher end compani expect
stryker corporationworldwid knee implant organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-yearsourc compani report corporationworldwid hip implant organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-yearsourc compani report least bp adjust oper margin expans year quarter benefit
transform growth program off-set dilut impact novadaq entellu acquisit
adjust oper margin perform led bp reduct adjust sg expens percent
sale expens also slightli lower anticip like reflect time issu flat
year-over-year perform adjust gross margin slightli better model modestli
improv price declin year-over-year versu year-over-year declin aid result
follow strong second quarter rais outlook organ growth
addit compani increas adjust ep guidanc versu consensu
expect posit organ growth adjust oper margin trend expect off-set less
favor anticip adjust ep impact currenc benefit expect versu
rais adjust ep estim reflect compani
out-performance continu expect promis result
summari deliv anoth quarter better-than-expect organ growth upsid consensu
adjust ep estim addit weak year margin perform encourag
improv perform area increas confid compani slightli exceed
upper end annual target bp adjust oper margin expans particularli anniversari
suppli headwind relat product hurrican maria overal remain posit
long-term outlook maintain buy rate new price target
stryker corporationannu incom statement analysi adjust northcoast research million except percentag per share gross gross sg intang oper oper net interest incom interest incom incom tax incom extra incom extra extra net net wghd com share ep ep growth ep growth start exclud acquistion-rel intang amort expens adjust ep compani report northcoast research estim disclosur
